Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 01, 2010 (Vol. 30, No. 3)

DrugDigest

URL:www.drugdigest.org/wps/portal/ddigest
  • Written in easy-to-understand language, depth of information
  • None

It certainly does grow tiresome, trying to read all of the microscopic print in medication advertisements or on pill bottles. Surely there must be a website to explain the purposes and risks of various medications. Enter DrugDigest, a noncommercial site “dedicated to empowering consumers to make informed choices about drugs and treatment options.” The site is written in a consumer-friendly way, organizing its material into questions such as, “What should I watch for while using this medication?”, “What if I miss a dose?”, and “When should I be careful taking it?” In addition to covering drugs and vitamins, the website also includes herbs and supplements. Visitors to the site can view pill images to ensure that they have the right drug, print a wallet-sized medication card, and peruse the medication checklist, a list of 13 facts one should know about each of one’s prescriptions.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »